FDA Approved: MITIGARE — Supplemental Application (Hikma Specialty USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for MITIGARE (colchicine) filed by Hikma Specialty USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Mediterranean Fever
• Gout
• Pericarditis

Drugs mentioned

• MITIGARE (Colchicine)

Snippet

SUPPL AP for MITIGARE (COLCHICINE)